Celgene Corporation

Registered Principal Details

Cessation Date
3/25/2020 1:18:32 PM

Business Or Interest:
Biopharmaceutical company.

Lobbying Interests:
Health care access to pharmaceuticals, biotechnology issues, and cancer drug repository programs.

CEO Name:
Mark Alles
Director of State Government Relations

Contact
HF
Helen Fitzpatrick
86 Morris Ave
Summit, NJ 07901
(202) 371-7559
jmannion@skadden.com
http://www.celgene.com

Authorized Lobbyists

Lobbyist Name Exclusive Duties Authorized On Withdrawn On
Helen Fitzpatrick Exclusive Duties No Authorized On 1/2/2019 Withdrawn On 3/26/2020
William J McCoshen Exclusive Duties No Authorized On 1/3/2019 Withdrawn On 3/26/2020
Patrick Gliha Exclusive Duties No Authorized On 2/20/2019 Withdrawn On 3/26/2020

Lobbying Interests

Legislative Bills/Resolutions

Assembly Bill 24
Assembly Bill 24
Relating to: step therapy protocols for prescription drug coverage and requiring the exercise of rule-making authority.

Bill Text and History

For
Notification Date
2/13/2019
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 26
Senate Bill 26
Relating to: step therapy protocols for prescription drug coverage and requiring the exercise of rule-making authority.

Bill Text and History

2019 Wisconsin Act 12

For
Notification Date
2/11/2019
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Topics Not Yet Assigned A Bill Or Rule Number

Issues relating to Step therapy & patient access legislation.
Development, drafting or introduction of a proposal relating to
Issues relating to Step therapy & patient access legislation.

Action Intended To Affect
Legislative matter

Notification Date
1/1/2019
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Total Lobbying Effort

  2019
January - June
2019
July - December
2020
January - June
Total
Total Lobbying Expenditures 2019
January - June
$111,352.06
2019
July - December
$31,948.56
2020
January - June
$0.00
Total $143,300.62
Total Hours Communicating 2019
January - June
112.25
2019
July - December
4.50
2020
January - June
0.00
Total 116.75
Total Hours Other 2019
January - June
197.50
2019
July - December
29.50
2020
January - June
0.00
Total 227.00

Percent Allocation of Lobbying Effort

Legislative Bills/Resolutions

Relating to: step therapy protocols for prescription drug coverage and requiring the exercise of rule-making authority.
2019
January - June
2019
July - December
2020
January - June
2020
July - December
Total
2019
January - June
46 %
2019
July - December
2020
January - June
2020
July - December
Total 41 %
Relating to: step therapy protocols for prescription drug coverage and requiring the exercise of rule-making authority.
2019
January - June
2019
July - December
2020
January - June
2020
July - December
Total
2019
January - June
46 %
2019
July - December
55 %
2020
January - June
2020
July - December
Total 47 %

Budget Bill Subjects

No budget bill subjects found.

Administrative Rulemaking Proceedings

No administrative rulemaking proceedings found.

Topics Not Yet Assigned A Bill Or Rule Number

2019
January - June
2019
July - December
2020
January - June
2020
July - December
Total
2019
January - June
8 %
2019
July - December
45 %
2020
January - June
2020
July - December
Total 12 %

Minor Efforts

No minor efforts found.

Other Matters

No other matters found.

Filed Statements of Lobbying Activity and Expenditures